Головна Спрощенний режим Відео-інструкція Опис
Авторизація
Прізвище
Пароль
 

Бази даних


Періодичні видання- результати пошуку

Вид пошуку

Зона пошуку
Формат представлення знайдених документів:
повнийінформаційнийкороткий
Відсортувати знайдені документи за:
авторомназвоюроком виданнятипом документа
Пошуковий запит: (<.>A=Poshyvak, O. B.$<.>)
Загальна кількість знайдених документів : 2
Показані документи з 1 по 2
1.
Шифр: УУ60/2021/93/2
   Журнал

The Ukrainian biochemical journal [Текст]. - Виходит раз на два місяця
2021р. Т. 93 № 2
Зміст:
Vari, S. G. Inflammation is the common mechanism of diseases (CMD) in COVID-19 disease during pregnancy and in gestational diabetes mellitus / S. G. Vari. - P.5
Kobylinska, L. In silico identification and biochemical validation of plausible molecular targets of 4-thiazolidinone derivative les-3833 as a potential anticancer agent / L. Kobylinska [et al.]. - P.7-23
Інші автори: Khylyuk D., Subtelna I., Kitsera M., Lesyk R.
Shevchuk, O. O. Locally delivered lovastatin-containing chitosan nanoparticles promote bone regeneration in rats / O. O. Shevchuk, Ya. V. Panasiuk, M. M. Korda. - P.24-38
Finiuk, N. S. Effect of a novel thiazole derivative and its complex with a polymeric carrier on stability of DNA in human breast cancer cells / N. S. Finiuk [et al.]. - P.39-52
Інші автори: Klyuchivska O. Yu., Ivasechko I. I., Mitina N. E., Ostapiuk Yu. V., Obushak M. D., Zaichenko O. S., Babsky A. M., Stoika R. S.
Poshyvak, O. B. Oxidative stress suppression contributes to antiseizure action of axitinib and rapamycin in pentylenetetrazol-induced kindling / O. B. Poshyvak, O. R. Pinyazhko, L. S. Godlevsky. - P.53-60
Korolova, D. S. Thromboelastographic study of fibrin clot and molecular basis of maximum clot firmness / D. S. Korolova [et al.]. - P.62-70
Інші автори: Stohnii Y. M., Gryshchuk V. I., Zhuk S. I., Us I. V., Chernyshenko T. M., Kostiuchenko O. P., Klymenko K. P., Platonov O. M., Ivashchenko O. I., Chernyshenko V. O.
Pavlyshyn, H. A. The association between vitamin D status and cardiometabolic disorders in overweight and obese adolescents / H. A. Pavlyshyn, A.-M. A. Shulha. - P.72-81
Pavlyshyn, H. A. Investigating the connections between night eating syndrome and metabolic syndrome in children / H. A. Pavlyshyn, K. V. Kozak, K. T. Hlushko. - P.83-94
Hlushko, K. T. Clinical and immunological peculiarities of parasitic infections in children with digestive system disorders in Western Ukraine / K. T. Hlushko, H. A. Pavlyshyn, K. V. Kozak. - P.96-105
Kucher, S. V. Inclusion of enterosorbents in anti-inflammatory therapy improve treatment effectiveness in COPD patients during exacerbations / S. V. Kucher, O. V. Lototska. - P.107-114
Danylova, T. V. Double Nobel prize winner: Frederick Sanger - the father of genomics / T. V. Danylova, S. V. Komisarenko. - P.116-122
Є примірники у відділах:
Прим. 1 (вільний)

Знайти схожі
Перейти до описів статей

2.


    Poshyvak, O. B.
    Oxidative stress suppression contributes to antiseizure action of axitinib and rapamycin in pentylenetetrazol-induced kindling / O. B. Poshyvak, O. R. Pinyazhko, L. S. Godlevsky // The Ukrainian biochemical journal. - 2021. - Vol. 93, № 2. - P53-60


MeSH-головна:
ПРОТИВОСУДОРОЖНЫЕ СРЕДСТВА -- ANTICONVULSANTS (терапевтическое применение)
СИРОЛИМУС -- SIROLIMUS (терапевтическое применение)
КОРАЗОЛ -- PENTYLENETETRAZOLE (терапевтическое применение)
ОКСИДАТИВНЫЙ СТРЕСС -- OXIDATIVE STRESS (физиология)
Анотація: Rapamycin and axitinib block different kinases in signaling pathways such as PI3K-Akt-mTOR and BDNF-TrkB, respectively. Both have antiseizure and antioxidative actions, which justify studying the combined effects of these drugs upon seizures and oxidative stress in the chronic model of epilepsy. The investigation aimed to look for the combined effect of rapamycin and axitinib upon pentylenetetrazol (PTZ)-kindled seizures and oxidative stress. Experiments were performed on 300 two- to four-month-old Wistar male rats, which had been kindled daily with PTZ (35.0 mg/kg, i.p.). Malondialdehyde (MDA) level, superoxide dismutase (SOD) activity, and glutathione (GSH) level were determined in brain tissues of kindled rats before and after the treatment. The analysis of antiseizure and antioxidative actions was performed using ED50 of rapamycin and axitinib, with their combined administration using graded dosages of ED50 of each drug. The median effective dose (ED50) for rapamycin and axitinib was 0.93 and 4.97 mg/kg, respectively. ED50 of rapamycin when combined with axitinib (2.0 mg/kg) was 0.60 mg/kg, which was reduced by 35.6% when compared with the ED50 administered alone (P 0.05). The MDA level increased from 152.9±24.8 to 388.3±49.2 nmol/mg of protein (P 0.05), while SOD activity reduced from 11.14±2.33 to 3.54±1.08 IU/mg of protein (P 0.05) in brain tissues of the kindled rats. Combined treatment with rapamycin (0.56 mg/kg, i.p.) and axitinib (2.0 mg/kg, i.p.) resulted in a significant rise in SOD activity (11.09±1.86 IU/mg) and GSH level (7.32±1.34 µg/mg) when compared with the kindled rats (P 0.05). Combined axitinib and rapamycin therapy have an antiepileptic and antioxidative effect on PTZ-kindled seizures
Дод.точки доступу:
Pinyazhko, O. R.
Godlevsky, L. S.
Sanger, Frederick (scientist in molecular biology, double Nobel Prize Winner ; 1918-2013) \о нем\

Вільних прим. немає

Знайти схожі

 
© Міжнародна Асоціація користувачів і розробників електронних бібліотек і нових інформаційних технологій
(Асоціація ЕБНІТ)